Whether this is a new diagnosis following a first episode of psychosis, or you are helping a family member navigate the medical aid system, this article addresses the practical coverage questions that matter most.
Does My Medical Aid Have to Cover This?
Yes. Schizophrenia is a CDL condition and is covered under the mental-health PMB (DTP 907T). Your scheme must: - Fund CDL-registered antipsychotic medications indefinitely. - Provide a minimum of 21 days acute inpatient psychiatric care per year. - Fund outpatient mental-health care as part of integrated schizophrenia management (the CMS guideline sets no fixed PMB visit count), from the chronic and day-to-day benefits.
Neither of these benefits can be denied on the basis of savings account balance or plan tier. They are legislated minimums.
Register for the CDL Benefit
Call your scheme's chronic benefits department and register the diagnosis. Required: - Psychiatrist's letter confirming schizophrenia (ICD-10: F20) - CDL registration form
Once CDL-registered, antipsychotic medications are funded from the CDL benefit — not from the medical savings account. This is significant: antipsychotic costs are lifelong, and protecting them from the MSA is important for long-term financial sustainability.
The PMB 21-Day Inpatient Limit: What It Means in Practice
The 21-day acute psychiatric inpatient PMB covers the acute stabilisation phase of a psychotic episode. Most acute admissions for schizophrenia relapse are resolved within 14–21 days on an optimised antipsychotic regimen.
If stabilisation requires longer than 21 days: - Request that the treating psychiatrist submit a clinical motivation to the scheme for extended authorisation. - The scheme is not obligated to fund beyond 21 days under PMB, but many do with adequate clinical justification. - Sub-acute rehabilitation or step-down care (if available) is an alternative to extended acute admission.
Long-Acting Injectables: Getting These Funded
LAI antipsychotics (paliperidone palmitate, aripiprazole LAI, risperidone LAI) are clinically superior to oral antipsychotics for relapse prevention in non-adherent patients. They may require exceptional-needs authorisation from your scheme.
Your psychiatrist's motivation should include: - History of non-adherence with oral antipsychotics - Relapse history (number of prior admissions and dates) - Clinical rationale for the specific LAI agent - Expected relapse-reduction benefit
Most schemes approve LAI applications with clear non-adherence documentation. The economics are also on your side — a single prevented hospitalisation costs far more than a year of LAI therapy.
Clozapine: Getting This Funded and Monitored
If two antipsychotics have been tried without adequate response, treatment-resistant schizophrenia (TRS) should be considered and clozapine initiated. Your scheme must fund clozapine under CDL for confirmed TRS.
Clozapine requires a specific monitoring programme. The scheme must fund both the medication and the mandatory white cell count monitoring tests. If your scheme is applying a co-payment to monitoring tests or classifying them as out-of-benefit, this is incorrect — write to the chronic benefits department citing CDL regulations.
Outpatient Follow-Up: Making Your Visits Count
The CMS schizophrenia guideline sets no fixed number of PMB outpatient visits — outpatient care is part of integrated schizophrenia management, funded from your chronic and day-to-day benefits. In schizophrenia, ongoing outpatient care typically means: - 4–6 psychiatrist visits for medication review - Remaining visits allocated to psychologist or social worker for psychosocial support
If your psychiatrist recommends more frequent visits than your day-to-day benefit covers (for instance, following an acute episode or during medication adjustment), ask them to motivate for additional visits through the scheme's exceptional-needs or mental health case management programme. Some schemes offer expanded mental health benefits for CDL-registered members enrolled in a mental health programme.
What Families and Caregivers Need to Know
Schizophrenia affects not just the individual but the entire family unit. Several practical points for families:
Power of attorney / medical proxy: If the person with schizophrenia is acutely unwell and unable to engage with the medical aid themselves, a family member with appropriate legal authority (e.g., healthcare proxy or power of attorney) may need to communicate with the scheme on their behalf. Ask your scheme about the process for authorised representatives before a crisis occurs.
Involuntary admission: Under the Mental Health Care Act (MHCA), a person who refuses treatment but poses a risk to themselves or others may be admitted involuntarily. PMB emergency psychiatric coverage applies regardless of voluntary or involuntary status. If involuntary admission is being considered, the treating clinician and the scheme must be engaged simultaneously.
Family psychoeducation: SADAG and SASOP both offer family psychoeducation resources. Understanding the condition reduces caregiver burnout and improves outcomes for the person with schizophrenia.
Communicating with the medical aid: The scheme's mental health case management line is your primary contact. Establish a relationship with the case manager assigned to the account — they can significantly smooth the administrative pathway, especially around renewal of exceptional-needs authorisations and inpatient extensions.
The Next Three Months: Checklist
| Action | Priority |
|---|---|
| Register for CDL benefit (ICD-10: F20) | Immediate |
| Confirm medications processed under CDL | Within 2 weeks |
| Confirm PMB inpatient and outpatient limits with scheme | This week |
| Ask about mental health disease management programme | With scheme |
| Check whether LAI requires exceptional-needs | At next psychiatrist appointment |
| Confirm gap cover is in place (for future hospitalisation shortfall) | This week |
Support Resources
SADAG (South African Depression and Anxiety Group): 0800 456 789 (24-hour) | www.sadag.org Mental health helpline, patient support, psychiatrist referrals
South African Society of Psychiatrists (SASOP): www.sasop.co.za Psychiatrist information and advocacy
What the PMB covers, in the regulation’s terms
- For schizophrenia and delusional disorders, the PMB is up to 3 weeks (21 days) a year of hospital-based care. (907T. Medical Schemes Act regulations, Annexure A.)
Talk to Eldon
Get help understanding your plan options →
This page is general information about medical schemes. It is not medical advice: speak to a healthcare professional about your own treatment. Medical aid and gap cover advice is given by Eldon de Waal, a Supervised Representative of Approach Administration (FSP 23579).